Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nasal mucosa integrates several distinct physiological systems, including trigeminal nerve endings, chemoreceptors, and the mucociliary apparatus, which collectively serve as the primary defense for the upper respiratory tract. The trigeminal nerve (CN V) provides extensive sensory innervation, detecting mechanical, thermal, and chemical irritants (chemesthesis) through molecular sensors like TRPV1 and TRPA1 channels (Silver et al., 2006, 'The Trigeminal System in the Nasal Cavity'). Nasal chemoreceptors, including solitary chemosensory cells, monitor the chemical environment and can trigger protective reflexes such as sneezing or changes in respiratory rate (Tizzano et al., 2010, 'Nasal solitary chemosensory cells'). The mucociliary apparatus consists of ciliated epithelial cells and a mucus layer that traps inhaled particles and pathogens, transporting them toward the pharynx for clearance (Bustamante-Marin & Ostrowski, 2017, 'Cilia and Mucociliary Clearance'). While this composite is not a single molecular target, its individual components are targeted by various pharmacological agents, such as decongestants, anticholinergics, and TRP channel modulators, to treat conditions like allergic rhinitis and chronic sinusitis. This system is critical for maintaining airway homeostasis and protecting the lungs from environmental insults.
Activation of transient receptor potential (TRP) channels on nerve endings, agonism of alpha-adrenergic receptors for vasoconstriction, antagonism of muscarinic receptors to reduce secretions, and physical hydration or enzymatic breakdown of mucus to facilitate clearance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trigeminal nerve endings, nasal chemoreceptors, and mucociliary apparatus in nasal mucosa.